New Trial Begins Testing Weekly Oral Risperidone Treatment for Schizophrenia
The LYNX drug development platform is able to deliver drug consistently, while minimizing peaks and troughs of drug levels compared to daily medicine.
Risperidone Lyn Johnm Kane Nayana Nagaraj Teva Pharmaceuticals Clinical Research At Lyndra Therapeutics Department Of Psychiatry
Source: hcplive.com